Copyright
©The Author(s) 2024.
World J Hepatol. May 27, 2024; 16(5): 703-715
Published online May 27, 2024. doi: 10.4254/wjh.v16.i5.703
Published online May 27, 2024. doi: 10.4254/wjh.v16.i5.703
Histone methylation | HMTs/HDMs | Mechanisms | Effects on glycolipid metabolism | Ref. |
H3K4me3↑ | MLL2/KMT2B | - | Regulation of glucose homeostasis | [20] |
H3K4me3↑ | MLL3/KMT2C | (+) KMT2C (2D) + PTIP→promoter (PPARγ) ←Transcript (C/EBPα); (+) KMT2C (2D) + PTIP→promoters (LPL, SREBF2, SCD1) ←Transcript (E2F1) | Lipid synthesis↑ | [21,23,68] |
MLL4/KMT2D | ||||
H3K9me2/3↑ | SUV39H1/KMT1A | (-) KMT1A (1D) →Transcript (C/EBPα) ←Enhancer (AP-2α); (-) KMT1D + PRDM16→promoter (HSD11B1) | Lipid synthesis↓ | [27,28] |
EHMT1/KMT1D | Blood glucose↑ | |||
H3K9me2/3↑ | EHMT2/KMT1C | (-) KMT1C→promoter (PPARγ) ←Transcript (C/EBPα); (+) KMT1C→Expression of HMGA1 | Lipid synthesis↓ | [30,31] |
Impaired insulin signal↓ | ||||
H3K27me3↑ | EZH2/KMT6A | (-) KMT6A→promoter (Mogat1) →MAG→DAG | Lipid synthesis↑ | [42,45] |
H3K79me1/2/↑ | DOT1L | (+) DOT1L→Pathways of SREBP | Lipid synthesis↑ | [49] |
(+) DOT1L→Brown and beige fat production and thermogenesis | ||||
H3K4me1/2↓ | LSD1/KDM1A | (-) KDM1A + PRDM16→promoter (HSD11B1) | Lipid synthesis↑ | [24,25] |
Blood glucose↓ | ||||
H3K9me2/me3↓ | JMJD2B/KDM4B | (+) KDM4B + PTIP→promoter (PPARγ) ←Transcript (C/EBPα) | Lipid synthesis↑ | [32,33] |
(+) KDM4B + LXRα | ||||
H3k9me3↓ | JMJD1C/KDM3C | (+) KDM3C + USF1→promoter; (Lipogenesis genes) | Lipid synthesis↑ | [34] |
H3K9me1/2↓ | JHDM2a/KDM3A | (+) KDM3A (β-adrenaline) →PPRE←promoter (PPARγ + RXRα) | Lipid synthesis↓ | [35,36] |
H3K9me2↓ | JHDM1D/KDM7A | (+) KDM7A→promoter (DGAT2) | Lipid synthesis↑ | [37] |
H3K27me2↓ | ||||
H3K27me3↓ | JMJD3/KDM6B | (+) KDM6B + islet1→promoter (SNAI1) | Lipid synthesis↓ | [46] |
H3K27me3↓ | - | (+) promoter (LepRb) →slug-Epigenetic reediting-Leptin resistance axis | Leptin resistance↑ | [48] |
H3K36me2↑ | NSD2 | (-) NSD2→promoter (PPARγ) | Lipid synthesis↓ | [47] |
H3K27me3↓ | ||||
H3K9me2/3↓ | Phf2 | (+) Phf2→ChREBP→promoter (FASN) | Lipid synthesis↑ | [39,40] |
Fructose decomposition↑ | ||||
H4K20me1↓ | KDM7B | (-) promoter (RNA Pol II) →H4K20me1→Expression of glycolytic genes | Lipid synthesis↑ | [55] |
H4K20me3↓ | - | (+) ChREBP→ChoRE + promoter (FASN) →H4K20me3→Expression of FASN | Lipid synthesis↑ | [53] |
- Citation: Xu L, Fan YH, Zhang XJ, Bai L. Unraveling the relationship between histone methylation and nonalcoholic fatty liver disease. World J Hepatol 2024; 16(5): 703-715
- URL: https://www.wjgnet.com/1948-5182/full/v16/i5/703.htm
- DOI: https://dx.doi.org/10.4254/wjh.v16.i5.703